SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001493152-18-012358
Filing Date
2018-08-20
Accepted
2018-08-20 16:46:32
Documents
48
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 form10-qa.htm 10-Q/A 821846
2 ex31-1.htm EX-31.1 19659
3 ex31-2.htm EX-31.2 11771
4 ex32-1.htm EX-32.1 8466
5 ex32-2.htm EX-32.2 8285
  Complete submission text file 0001493152-18-012358.txt   3340377

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE prph-20170630.xml EX-101.INS 482740
7 XBRL SCHEMA FILE prph-20170630.xsd EX-101.SCH 38979
8 XBRL CALCULATION FILE prph-20170630_cal.xml EX-101.CAL 52515
9 XBRL DEFINITION FILE prph-20170630_def.xml EX-101.DEF 121511
10 XBRL LABEL FILE prph-20170630_lab.xml EX-101.LAB 277736
11 XBRL PRESENTATION FILE prph-20170630_pre.xml EX-101.PRE 196978
Mailing Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901
Business Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901 2153450919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-21617 | Film No.: 181028668
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences